CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
Viral Aggregation in Downstream Processing of Lentiviral Vectors
What is a Bioreactor and How is it Used in Cell and Gene Therapy?
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
Road to success: Understanding Good Laboratory Practice for cell and gene therapies
12 Aug 2020

CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)

Outsourcing to a contract development and manufacturing organization (...

17 Apr 2020

Quality-by-Design Approach to Manufacturing Cell and Gene Therapies

Implementation of a manufacturing process that assures a predefined qu...

30 Oct 2019

Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant

When we think about cell and gene therapies (CGTs) what most often com...

30 Oct 2019

Considerations for the Use of Stable Producer Lines in the Manufacturing of Lentiviral Vectors

In an introductory post on lentiviral vector (LVV) manufacturing for c...

30 Oct 2019

Planning Is Everything - Quality Control Testing in Cell and Gene Therapy

Compliance with quality control (QC) standards is a basic requirement ...

29 Oct 2019

How to Scale-Up Lentiviral Vector Production Part 1: Considerations for Upstream Processing

Lentiviral vectors (LVV) are a key component in the production of cell...

24 Oct 2019

IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?

Understanding the cell and gene therapy (CGT) development process from...

05 Sep 2019

What Is the Best Way to Manufacture Lentiviral Vectors for Cell and Gene Therapies?

In the field of cell and gene therapy, there are two main types of vir...

01 Sep 2019

How Do CAR-T Cells Work to Engineer a Patient's Immune System to Fight Cancer?

Conventional cancer treatments (e.g. surgery, chemotherapy/radiation) ...

Tell us what you thought about this post.